
GLP-1 receptor agonists show promise in treating substance use disorders
A systematic review examined the potential of GLP-1 receptor agonists in reducing substance use disorders. Findings from available clinical trials showed inconsistent results due to study variability and patient differences. Substance use disorders, such as alcohol, nicotine, and cocaine, are a significant public health concern, with increasing prevalence and mortality rates globally. GLP-1 receptor agonists,…